#FutureReadyHealthcare

Who We AreInvestor RelationsNewsCareers
Indegene

XyloCor chooses Indegene's MME to assess PRMA landscape for refractory angina

Back to Videos

Related Insights

Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies
4:05

Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies

Let’s partner for #FutureReadyHealthcare

© 2023 Indegene. All Rights Reserved.  

Privacy PolicyCSR PolicyIndegene Speak Up